121 related articles for article (PubMed ID: 21852855)
1. Iron dextran complex.
National Toxicology Program
Rep Carcinog; 2011; 12():246-7. PubMed ID: 21852855
[No Abstract] [Full Text] [Related]
2. Iron dextran complex.
Rep Carcinog; 2004; 11():III155-6. PubMed ID: 21089896
[No Abstract] [Full Text] [Related]
3. Iron dextran complex.
National Toxicology Program
Rep Carcinog; 2002; 10():140-1. PubMed ID: 15326663
[No Abstract] [Full Text] [Related]
4. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2011; 61(7):399-410. PubMed ID: 21899208
[TBL] [Abstract][Full Text] [Related]
5. Estrogens, steroidal.
National Toxicology Program
Rep Carcinog; 2011; 12():184-8. PubMed ID: 21852836
[No Abstract] [Full Text] [Related]
6. Evaluation of the potential carcinogenic and co-carcinogenic action of drugs (injectable organic iron complexes).
Neukomm S
Oncologia; 1965; 19(3):239-53. PubMed ID: 5863392
[No Abstract] [Full Text] [Related]
7. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
Roth S; Langguth P; Spicher K; Enzmann H
Transl Res; 2008 Jan; 151(1):36-44. PubMed ID: 18061126
[TBL] [Abstract][Full Text] [Related]
8. The toxic effects of iron-dextran complex on mammalian cells in tissue culture.
RICHMOND HG
Br J Cancer; 1961 Sep; 15(3):594-606. PubMed ID: 14492016
[No Abstract] [Full Text] [Related]
9. Norethisterone.
National Toxicology Program
Rep Carcinog; 2002; 10():189. PubMed ID: 15328588
[No Abstract] [Full Text] [Related]
10. Differential induction of polyamine oxidase activity in liver and heart of iron-overloaded rats.
Tipnis UR; He GY; Khan MF
J Toxicol Environ Health; 1997 Jun; 51(3):235-44. PubMed ID: 9183380
[TBL] [Abstract][Full Text] [Related]
11. Chlorambucil.
National Toxicology Program
Rep Carcinog; 2002; 10():47-8. PubMed ID: 15318384
[No Abstract] [Full Text] [Related]
12. Wood dust.
National Toxicology Program
Rep Carcinog; 2002; 10():260-3. PubMed ID: 15341004
[No Abstract] [Full Text] [Related]
13. Danthron (1,8-dihydroxyanthraquinone).
National Toxicology Program
Rep Carcinog; 2002; 10():76-7. PubMed ID: 15323026
[No Abstract] [Full Text] [Related]
14. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
Sav T; Tokgoz B; Sipahioglu MH; Deveci M; Sari I; Oymak O; Utas C
Ren Fail; 2007; 29(4):423-6. PubMed ID: 17497463
[TBL] [Abstract][Full Text] [Related]
15. Ethylene oxide.
National Toxicology Program
Rep Carcinog; 2011; 12():188-91. PubMed ID: 21852837
[No Abstract] [Full Text] [Related]
16. Cisplatin.
National Toxicology Program
Rep Carcinog; 2002; 10():67-8. PubMed ID: 15320329
[No Abstract] [Full Text] [Related]
17. Dacarbazine.
National Toxicology Program
Rep Carcinog; 2002; 10():75-6. PubMed ID: 15323025
[No Abstract] [Full Text] [Related]
18. 1,2-Dibromo-3-chloropropane.
National Toxicology Program
Rep Carcinog; 2011; 12():134-5. PubMed ID: 21852817
[No Abstract] [Full Text] [Related]
19. Epichlorohydrin.
National Toxicology Program
Rep Carcinog; 2011; 12():180-3. PubMed ID: 21852834
[No Abstract] [Full Text] [Related]
20. Diglycidyl resorcinol ether.
National Toxicology Program
Rep Carcinog; 2011; 12():163-4. PubMed ID: 21852825
[No Abstract] [Full Text] [Related]
[Next] [New Search]